American Journal of Kidney Diseases
Volume 46, Issue 6 , Pages 997-1011 , December 2005

The Use of Vaccines in Adult Patients With Renal Disease

Received 15 April 2005 ,Accepted 23 August 2005.

References 

  1. US Renal Data System . USRDS 2004 Annual Data Report . Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2004;
  2. Furth SL , Neu AM , Sullivan EK , Gensler G , Tejani A , Fivush BA . Immunization practices in children with renal disease (A report of the North American Pediatric Renal Transplant Cooperative Study) . Pediatr Nephrol . 1997;11:443–446
  3. Recommended adult immunization schedule—US, 10/2004-9/05 . MMWR Morb Mortal Wkly Rep . 2004;53:Q1–Q4
  4. Pesanti EL . Infections in patients with CRF . Infect Dis Clin North Am . 2001;15:1–15
  5. Recommendations for preventing transmission of infections among chronic HD patients . MMWR Morb Mortal Wkly Rep . 2001;50:1–43
  6. Ribot S , Rothstein M , Goldblat M , Grasso M . Duration of hepatitis B surface antigenemia (HBsAg) in hemodialysis patients . Arch Intern Med . 1979;139:178–180
  7. US Department of Health, Education and Welfare Public Health Services, CDC . Hepatitis (Control Measures for Hepatitis B in Dialysis Centers) . 1977; Atlanta, GA, CDC, HEW publication no. 78-8358
  8. Tokars JI , Finelli L , Alter MJ , Arduino MJ . National surveillance of dialysis-associated diseases in the United States, 2001 . Semin Dial . 2004;17:310–319
  9. Outbreaks of hepatitis B infection among HD patients—California, Nebraska, Texas, 1994 . MMWR Morb Mortal Wkly Rep . 1996;45:285–289
  10. Hutin YJ , Goldstein ST , Varma JK , et al.   An outbreak of hospital-acquired hepatitis B virus infection among patients receiving chronic hemodialysis . Infect Control Hosp Epidemiol . 1999;20:731–735
  11. Palmovic D , Crnjakovic-Palmovic J . Vaccination against hepatitis B (Results of the analysis of 2000 population members in Croatia) . Eur J Epidemiol . 1994;10:541–547
  12. Miller ER , Alter MJ , Tokars JI . Protective effect of hepatitis B vaccine in chronic hemodialysis patients . Am J Kidney Dis . 1999;33:356–360
  13. West DJ , Calandra GB . Vaccine induced immunologic memory for hepatitis B surface antigen (Implications for policy on booster vaccination) . Vaccine . 1996;14:1019–1027
  14. Stevens CE , Alter HJ , Taylor PE , Zang EA , Harley EJ , Szmuness W . Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy . N Engl J Med . 1984;311:496–501
  15. Saab S , Weston SR , Ly D , et al.   Comparison of the cost and effectiveness of two strategies for maintaining hepatitis B immunity in hemodialysis patients . Vaccine . 2002;20:3230–3235
  16. Charest AF , McDougall J , Goldstein MB . A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients . Am J Kidney Dis . 2000;36:976–982
  17. Propst T , Propst A , Lhotta K , Vogel W , Konig P . Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination . Am J Kidney Dis . 1998;32:1041–1045
  18. Fabrizi F , Andrulli S , Bacchini G , Corti M , Locatelli F . Intradermal versus intramuscular hepatitis B re-vaccination in non-responsive chronic dialysis patients (A prospective randomized study with cost-effectiveness evaluation) . Nephrol Dial Transplant . 1997;12:1204–1211
  19. Hess G , Kreiter F , Kosters W , Deusch K . The effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on hepatitis B vaccination in haemodialysis patients . J Viral Hepat . 1996;3:149–153
  20. Jungers P , Devillier P , Salomon H , Cerisier JE , Courocuce AM . Randomised placebo-controlled trial of recombinant interleukin in chronic uraemic patients who are non-responders to hepatitis vaccine . Lancet . 1994;344:856–857
  21. Mauri JM , Valles M . Effects of recombinant interleukin-2 and revaccination for hepatitis B in previously vaccinated, non-responder, chronic uraemic patients. Collaborative Group of Girona . Nephrol Dial Transplant . 1997;12:729–732
  22. Cooper CL , Davis HL , Morris ML , et al.   CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults (A double-blind phase I/II study) . J Clin Immunol . 2004;24:693–701
  23. Halperin SA , Van Nest G , Smith B , Abtahi S , Whiley H , Eiden JJ . A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant . Vaccine . 2003;21:2461–2467
  24. Verthelyi D , Wang VW , Lifson JD , Klinman DM . CpG oligodeoxynucleotides improve the response to hepatitis B immunization in healthy and SIV-infected rhesus macaques . AIDS . 2004;18:1003–1008
  25. Agarwal SK , Irshad M , Dash SC . Comparison of two schedules of hepatitis B vaccination in patients with mild, moderate and severe renal failure . J Assoc Physicians India . 1999;47:183–185
  26. DaRoza G , Loewen A , Djurdjev O , et al.   Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization (Earlier is better) . Am J Kidney Dis . 2003;42:1184–1192
  27. Dukes CS , Street AC , Starling JF , Hamilton JD . Hepatitis B vaccination and booster in predialysis patients (A 4-year analysis) . Vaccine . 1993;11:1229–1232
  28. Oddone EZ , Cowper PA , Hamilton JD , Feussner JR . A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients . Health Serv Res . 1993;28:97–121
  29. Mathurin P , Mouquet C , Poynard T , et al.   Impact of hepatitis B and C virus on kidney transplantation outcome . Hepatology . 1999;29:257–263
  30. Jacobson IM , Jaffers G , Dienstag JL , et al.   Immunogenicity of hepatitis B vaccine in renal transplant recipients . Transplantation . 1985;39:393–395
  31. Lefebure AF , Verpooten GA , Couttenye MM , De Broe ME . Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients . Vaccine . 1993;11:397–399
  32. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP) . MMWR Morb Mortal Wkly Rep . 1991;40:1–25
  33. Slinin Y , Foley RN , Collins AJ . Clinical epidemiology of pneumonia in hemodialysis patients . J Am Soc Nephrol . 2004;15:SA-PO427; (abstr)
  34. Khan IH , Catto GR . Long-term complications of dialysis (Infection) . Kidney Int Suppl . 1993;41:S143–S148
  35. Pazik J , Durlik M , Lewandowska D , et al.   Pneumonia in kidney allograft recipients . Transplant Proc . 2003;35:2202–2204
  36. Sarnak MJ , Jaber BL . Pulmonary infectious mortality among patients with end-stage renal disease . Chest . 2001;120:1883–1887
  37. Prevention of pneumoccal disease (Recommendations of the Advisory Committee on Immunization Practices (ACIP)) . MMWR Recomm Rep . 1997;46:1–24
  38. Jackson LA , Neuzil KM , Yu O , et al.   Effectiveness of pneumococcal polysaccharide vaccine in older adults . N Engl J Med . 2003;348:1747–1755
  39. Katz LA , Simberkoff MS , Schiffman G , et al.   Pneumococcal capsular polysaccharide vaccination in adult chronic hemodialysis patients . Trans Am Soc Artif Intern Organs . 1980;26:369–371
  40. Nikoskelainen J , Koskela M , Forsstrom J , Kasanen A , Leinonen M . Persistence of antibodies to pneumococcal vaccine in patients with chronic renal failure . Kidney Int . 1985;28:672–677
  41. Rytel MW , Dailey MP , Schiffman G , Hoffmann RG , Piering WF . Pneumococcal vaccine immunization of patients with renal impairment . Proc Soc Exp Biol Med . 1986;182:468–473
  42. Fuchshuber A , Kuhnemund O , Keuth B , Lutticken R , Michalk D , Querfeld U . Pneumococcal vaccine in children and young adults with chronic renal disease . Nephrol Dial Transplant . 1996;11:468–473
  43. Kumar D , Rotstein C , Miyata G , Arlen D , Humar A . Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients . J Infect Dis . 2003;187:1639–1645
  44. Cosio FG , Giebink GS , Le CT , Schiffman G . Pneumococcal vaccination in patients with chronic renal disease and renal allograft recipients . Kidney Int . 1981;20:254–258
  45. Silberman H , Overturf GD , Field RJ , Butler J , Berne TV , Witt R . Response of renal allograft recipients to pneumococcal vaccine . Ann Surg . 1980;192:199–201
  46. Recommendation of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP) . MMWR Morb Mortal Wkly Rep . 2002;51:1–36
  47. Linnemann CC , First MR , Schiffman G . Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine . Arch Intern Med . 1986;146:1554–1556
  48. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP) . MMWR Morb Mortal Wkly Rep . 2003;52:1–36
  49. Eickhoff TC , Sherman IL , Serfling RE . Observations on excess mortality associated with epidemic influenza . JAMA . 1961;176:776–782
  50. Beyer WE , Versluis DJ , Kramer P , Diderich PP , Weimar W , Masurel N . Trivalent influenza vaccine in patients on haemodialysis (Impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine components) . Vaccine . 1987;5:43–48
  51. Ortbals DW , Marks ES , Liebhaber H . Influenza immunization in patients with chronic renal disease . JAMA . 1978;239:2562–2565
  52. Osanloo EO , Berlin BS , Popli S , et al.   Antibody responses to influenza vaccination in patients with chronic renal failure . Kidney Int . 1978;14:614–618
  53. Antonen JA , Hannula PM , Pyhala R , Saha HH , Ala-Houhala IO , Pasternack AI . Adequate seroresponse to influenza vaccination in dialysis patients . Nephron . 2000;86:56–61
  54. Vogtlander NP , Brown A , Valentijn RM , Rimmelzwaan GF , Osterhaus AD . Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients . Vaccine . 2004;22:2199–2201
  55. Ahmed AE , Nicholson KG , Nguyen-Van-Tam JS . Reduction in mortality associated with influenza vaccine during 1989-90 epidemic . Lancet . 1995;346:591–595
  56. Gilbertson DT , Unruh M , McBean AM , Kausz AT , Snyder JJ , Collins AJ . Influenza vaccine delivery and effectiveness in end-stage renal disease . Kidney Int . 2003;63:738–743
  57. Nichol KL , Nordin J , Mullooly J , Lask R , Fillbrandt K , Iwane M . Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly . N Engl J Med . 2003;348:1322–1332
  58. Gurfinkel EP , de la Fuente RL , Mendiz O , Mautner B . Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions (The FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study) . Circulation . 2002;105:2143–2147
  59. Naghavi M , Barlas Z , Siadaty S , Naguib S , Madjid M , Casscells W . Association of influenza vaccination and reduced risk of recurrent myocardial infarction . Circulation . 2000;102:3039–3045
  60. Vilchez RA , McCurry K , Dauber J , et al.   Influenza virus infection in adult solid organ transplant recipients . Am J Transplant . 2002;2:287–291
  61. Sanchez-Fructuoso AI , Prats D , Naranjo P , et al.   Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols (Mycophenolate versus azathioprine) . Transplantation . 2000;69:436–439
  62. Girndt M , Pietsch M , Kohler H . Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure . Am J Kidney Dis . 1995;26:454–460
  63. Kruger S , Muller-Steinhardt M , Kirchner H , Kreft B . A 5-year follow-up on antibody response after diphtheria and tetanus vaccination in hemodialysis patients . Am J Kidney Dis . 2001;38:1264–1270
  64. Guerin A , Buisson Y , Nutini MT , Saliou P , London G , Marchais S . Response to vaccination against tetanus in chronic haemodialysed patients . Nephrol Dial Transplant . 1992;7:323–326
  65. Huzly D , Neifer S , Reinke P , et al.   Routine immunizations in adult renal transplant recipients . Transplantation . 1997;63:839–845
  66. Diphtheria, tetanus, and pertussis: Recommendations for vaccine use and other preventive measures: Recommendations of the Immunization Practices Advisory Committee (ACIP) . MMWR Morb Mortal Wkly Rep . 1991;40:2–28
  67. Update (Diphtheria epidemic—New independent states of the Former Soviet Union) . MMWR Morb Mortal Wkly Rep . 1996;45: 693-691
  68. Vitek CR , Wharton M . Diphtheria in the former Soviet Union (Reemergence of a pandemic disease) . Emerg Infect Dis . 1998;4:539–550
  69. Enke BU , Bokenkamp A , Offner G , Bartmann P , Brodehl J . Response to diphtheria and tetanus booster vaccination in pediatric renal transplant recipients . Transplantation . 1997;64:237–241
  70. Leach CT . Hepatitis A in the United States . Pediatr Infect Dis J . 2004;23:551–552
  71. Niu MT , Polish LB , Robertson BH , et al.   Multistate outbreak of hepatitis A associated with frozen strawberries . J Infect Dis . 1992;166:518–524
  72. Stark K , Gunther M , Neuhaus R , et al.   Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients . J Infect Dis . 1999;180:2014–2017
  73. Keeffe EB . Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? . Am J Gastroenterol . 1995;90:201–205
  74. Werzberger A , Mensch B , Kuter B , et al.   A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children . N Engl J Med . 1992;327:453–457
  75. Werzberger A , Kuter B , Nalin D . Six years’ follow-up after hepatitis A vaccination . N Engl J Med . 1998;338:1160
  76. Niu MT , Salive M , Krueger C , Ellenberg SS . Two-year review of hepatitis A vaccine safety (Data from the Vaccine Adverse Event Reporting System (VAERS)) . Clin Infect Dis . 1998;26:1475–1476
  77. Kuramoto I , Fujiyama S , Matsushita K , Sato T . Immune response after hepatitis A vaccination in haemodialysis patients (Comparison with hepatitis B vaccination) . J Gastroenterol Hepatol . 1994;9:228–231
  78. Lemon SM , Thomas DL . Vaccines to prevent viral hepatitis . N Engl J Med . 1997;336:196–204
  79. Keeffe EB . Vaccination against hepatitis A and B in patients with chronic liver disease . Viral Hepat Rev . 1999;5:77–88
  80. Fleishmann EH , Kruppenbacher J , Bock HL , Weber M . Active immunization against hepatitis A in dialysis patients . Nephrol Dial Transplant . 2002;17:1825–1828
  81. Centers for Disease Control and Prevention . Varicella-related deaths among adults (United States, 1997) . MMWR Morb Mortal Wkly Rep . 1997;46:409–412
  82. Fehr T , Bossart W , Wahl C , Binswanger U . Disseminated varicella infection in adult renal allograft recipients (Four cases and a review of the literature) . Transplantation . 2002;73:608–611
  83. Zamora I , Simon JM , Da Silva ME , Piqueras AI . Attenuated varicella virus vaccine in children with renal transplants . Pediatr Nephrol . 1994;8:190–192
  84. Broyer M , Tete MJ , Guest G , Gagnadoux MF , Rouzioux C . Varicella and zoster in children after kidney transplantation (Long-term results of vaccination) . Pediatrics . 1997;99:35–39
  85. Webb NJ , Fitzpatrick MM , Hughes DA , et al.   Immunisation against varicella in end stage and pre-end stage renal failure. Trans-Pennine Paediatric Nephrology Study Group . Arch Dis Child . 2000;82:141–143
  86. Gourishankar S , McDermid JC , Jhangri GS , Preiksaitis JK . Herpes zoster infection following solid organ transplantation (Incidence, risk factors and outcomes in the current immunosuppressive era) . Am J Transplant . 2004;4:108–115
  87. Hata A , Asanuma H , Rinki M , et al.   Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants . N Engl J Med . 2002;347:26–34
  88. Centers for Disease Control and Prevention . Prevention of varicella (Recommendations of the Advisory Committee on Immunization Practices (ACIP)) . MMWR Morb Mortal Wkly Rep . 1996;45:1–36
  89. Kessler M , Hoen B , Mayeux D , Hestin D , Fontenaille C . Bacteremia in patients on chronic hemodialysis. A multicenter prospective survey . Nephron . 1993;64:95–100
  90. Danese M, Dylan M, Dubois R, Hsing-Ting Y, Griffiths R, Nissenson A: Mortality in hemodialysis patients hospitalized with septicemia caused by S aureus. Presented at the American Society of Nephrology 2004 Annual Meeting (abstr)
  91. Poole-Warren LA , Hallett MD , Hone PW , Burden SH , Farrell PC . Vaccination for prevention of CAPD associated staphylococcal infection (Results of a prospective multicentre clinical trial) . Clin Nephrol . 1991;35:198–206
  92. Shinefield H , Black S , Fattom A , et al.   Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis . N Engl J Med . 2002;346:491–496

 The data reported here have been supplied by the US Renal Data System. The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as an official policy or interpretation of the US government.Originally published online as doi:10.1053/j.ajkd.2005.08.032 on November 3, 2005.

PII: S0272-6386(05)01331-4

doi: 10.1053/j.ajkd.2005.08.032

American Journal of Kidney Diseases
Volume 46, Issue 6 , Pages 997-1011 , December 2005

Article Tools

* Image Usage & Resolution